Cargando…

Aberrant stromal tissue factor localisation and mycolactone-driven vascular dysfunction, exacerbated by IL-1β, are linked to fibrin formation in Buruli ulcer lesions

Buruli ulcer (BU) is a neglected tropical disease caused by subcutaneous infection with Mycobacterium ulcerans and its exotoxin mycolactone. BU displays coagulative necrosis and widespread fibrin deposition in affected skin tissues. Despite this, the role of the vasculature in BU pathogenesis remain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsieh, Louise Tzung-Harn, Dos Santos, Scott J., Hall, Belinda S., Ogbechi, Joy, Loglo, Aloysius D., Salguero, Francisco Javier, Ruf, Marie-Thérèse, Pluschke, Gerd, Simmonds, Rachel E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846541/ https://www.ncbi.nlm.nih.gov/pubmed/35100311 http://dx.doi.org/10.1371/journal.ppat.1010280

Ejemplares similares

Mycolactone-Dependent Depletion of Endothelial Cell Thrombomodulin Is Strongly Associated with Fibrin Deposition in Buruli Ulcer Lesions
por: Ogbechi, Joy, et al.
Publicado: (2015)

Infiltrating leukocytes surround early Buruli ulcer lesions, but are unable to reach the mycolactone producing mycobacteria
por: Ruf, Marie-Thérèse, et al.
Publicado: (2017)

The One That Got Away: How Macrophage-Derived IL-1β Escapes the Mycolactone-Dependent Sec61 Blockade in Buruli Ulcer
por: Hall, Belinda S., et al.
Publicado: (2022)

Inhibition of the SEC61 translocon by mycolactone induces a protective autophagic response controlled by EIF2S1-dependent translation that does not require ULK1 activity
por: Hall, Belinda S, et al.
Publicado: (2021)

The Pathogenic Mechanism of the Mycobacterium ulcerans Virulence Factor, Mycolactone, Depends on Blockade of Protein Translocation into the ER
por: Hall, Belinda S., et al.
Publicado: (2014)

Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease
por: Sarfo, Fred Stephen, et al.
Publicado: (2015)

Metabolomic profiles delineate mycolactone signature in Buruli ulcer disease
por: Niang, Fatoumata, et al.
Publicado: (2015)

Inhibition of Sec61-dependent translocation by mycolactone uncouples the integrated stress response from ER stress, driving cytotoxicity via translational activation of ATF4
por: Ogbechi, Joy, et al.
Publicado: (2018)

Development of an ELISA for the quantification of mycolactone, the cytotoxic macrolide toxin of Mycobacterium ulcerans
por: Warryn, Louisa, et al.
Publicado: (2020)

Immunohistochemical Monitoring of Wound Healing in Antibiotic Treated Buruli Ulcer Patients
por: Andreoli, Arianna, et al.
Publicado: (2014)

Mycolactone causes catastrophic Sec61-dependent loss of the endothelial glycocalyx and basement membrane: a new indirect mechanism driving tissue necrosis in Mycobacterium ulcerans infection
por: Hsieh, Louise Tzung-Harn, et al.
Publicado: (2023)

Mycolactone enhances the Ca(2+) leak from endoplasmic reticulum by trapping Sec61 translocons in a Ca(2+) permeable state
por: Bhadra, Pratiti, et al.
Publicado: (2021)

Local Cellular Immune Responses and Pathogenesis of Buruli Ulcer Lesions in the Experimental Mycobacterium Ulcerans Pig Infection Model
por: Bolz, Miriam, et al.
Publicado: (2016)

Mycolactone cytotoxicity in Schwann cells could explain nerve damage in Buruli ulcer
por: En, Junichiro, et al.
Publicado: (2017)

Experimental Infection of the Pig with Mycobacterium ulcerans: A Novel Model for Studying the Pathogenesis of Buruli Ulcer Disease
por: Bolz, Miriam, et al.
Publicado: (2014)

Mycolactone Diffuses into the Peripheral Blood of Buruli Ulcer Patients - Implications for Diagnosis and Disease Monitoring
por: Sarfo, Fred S., et al.
Publicado: (2011)

RNA Aptamer That Specifically Binds to Mycolactone and Serves as a Diagnostic Tool for Diagnosis of Buruli Ulcer
por: Sakyi, Samuel A., et al.
Publicado: (2016)

What about Current Diversity of Mycolactone-Producing Mycobacteria? Implication for the Diagnosis and Treatment of Buruli Ulcer
por: Combe, Marine, et al.
Publicado: (2023)

Structure-Activity Relationship Studies on the Macrolide Exotoxin Mycolactone of Mycobacterium ulcerans
por: Scherr, Nicole, et al.
Publicado: (2013)

Secondary Buruli Ulcer Skin Lesions Emerging Several Months after Completion of Chemotherapy: Paradoxical Reaction or Evidence for Immune Protection?
por: Ruf, Marie-Thérèse, et al.
Publicado: (2011)

Spatial Distribution of Mycobacterium ulcerans in Buruli Ulcer Lesions: Implications for Laboratory Diagnosis
por: Ruf, Marie-Thérèse, et al.
Publicado: (2016)

Selamectin Is the Avermectin with the Best Potential for Buruli Ulcer Treatment
por: Scherr, Nicole, et al.
Publicado: (2015)

Distribution and Risk of Mycolactone-Producing Mycobacteria Transmission within Buruli Ulcer Endemic Communities in Côte d’Ivoire
por: Dassi, Christelle, et al.
Publicado: (2017)

Histopathological Changes and Clinical Responses of Buruli Ulcer Plaque Lesions during Chemotherapy: A Role for Surgical Removal of Necrotic Tissue?
por: Ruf, Marie-Thérèse, et al.
Publicado: (2011)

Cellular Immunity Confers Transient Protection in Experimental Buruli Ulcer following BCG or Mycolactone-Negative Mycobacterium ulcerans Vaccination
por: Fraga, Alexandra G., et al.
Publicado: (2012)

Mycolactone Gene Expression Is Controlled by Strong SigA-Like Promoters with Utility in Studies of Mycobacterium ulcerans and Buruli Ulcer
por: Tobias, Nicholas J., et al.
Publicado: (2009)

Mycolactone toxin induces an inflammatory response by targeting the IL-1β pathway: Mechanistic insight into Buruli ulcer pathophysiology
por: Foulon, M., et al.
Publicado: (2020)

Secondary Bacterial Infections of Buruli Ulcer Lesions Before and After Chemotherapy with Streptomycin and Rifampicin
por: Yeboah-Manu, Dorothy, et al.
Publicado: (2013)

Buruli ulcer: The Efficacy of Innate Immune Defense May Be a Key Determinant for the Outcome of Infection With Mycobacterium ulcerans
por: Röltgen, Katharina, et al.
Publicado: (2020)

Mycobacterium ulcerans Persistence at a Village Water Source of Buruli Ulcer Patients
por: Bratschi, Martin W., et al.
Publicado: (2014)

Local Heat Application for the Treatment of Buruli Ulcer: Results of a Phase II Open Label Single Center Non Comparative Clinical Trial
por: Vogel, Moritz, et al.
Publicado: (2016)

Identification of the Mycobacterium ulcerans Protein MUL_3720 as a Promising Target for the Development of a Diagnostic Test for Buruli Ulcer
por: Dreyer, Anita, et al.
Publicado: (2015)

Correction: Mycolactone Gene Expression Is Controlled by Strong SigA-Like Promoters with Utility in Studies of Mycobacterium ulcerans and Buruli Ulcer
por: Tobias, Nicholas J., et al.
Publicado: (2010)

Mycolactone-mediated neurite degeneration and functional effects in cultured human and rat DRG neurons: Mechanisms underlying hypoalgesia in Buruli ulcer
por: Anand, U, et al.
Publicado: (2016)

Molecular Characterization of Mycolactone Producing Mycobacteria from Aquatic Environments in Buruli Ulcer Non-Endemic Areas in Côte d’Ivoire
por: Tano, Marcellin B., et al.
Publicado: (2017)

Single Nucleotide Polymorphism Typing of Mycobacterium ulcerans Reveals Focal Transmission of Buruli Ulcer in a Highly Endemic Region of Ghana
por: Röltgen, Katharina, et al.
Publicado: (2010)

Co-infection of HIV in patients with Buruli ulcer disease in Central Ghana
por: Amoako, Yaw Ampem, et al.
Publicado: (2021)

Antibody-Mediated Neutralization of the Exotoxin Mycolactone, the Main Virulence Factor Produced by Mycobacterium ulcerans
por: Dangy, Jean-Pierre, et al.
Publicado: (2016)

Alternative boronic acids in the detection of Mycolactone A/B using the thin layer chromatography (f-TLC) method for diagnosis of Buruli ulcer
por: Akolgo, Gideon A., et al.
Publicado: (2023)

Mycobacterium ulcerans DNA in Bandicoot Excreta in Buruli Ulcer–Endemic Area, Northern Queensland, Australia
por: Röltgen, Katharina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f12kejlgifm7rf6b246k3qir8n